Public-registry site landscape for NCT05127434, a Respiratory Syncytial Virus study sponsored by ModernaTX, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05127434 (registry record) |
| Sponsor | ModernaTX, Inc. |
| Condition(s) | Respiratory Syncytial Virus |
| Phase | PHASE2 / PHASE3 |
| Listed sites | 269 |
| Site countries | United States, Argentina, Australia, Bangladesh, Belgium, Canada, Chile, Colombia, Costa Rica, Finland, Germany, Japan |
Eichor generates a preliminary site-risk snapshot for NCT05127434 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →